CEO Serge Saxonov, PhD, acknowledged that its R&D operation “definitely ended up being impacted in a substantial way” while sales operations were less impacted since the company reorganized its sales ...

TAHITI couples CRISPR with transposable elements from plants to edit cash crops such as corn and soybean with reduced ...

Imprint has raised $15 million to decode the body's immune memory for understanding chronic diseases, such as long-COVID and ...

Treated with an individualized gene-editing therapy that corrects mutations directly on the genome, a patient shows improvement from a rare metabolic disease.